All AbMole products are for research use only, cannot be used for human consumption.
Shikonin (C.I. 75535, Anchusin, Anchusa acid, Alkanna Red, Isoarnebin 4, NSC 252844) is an effective and specific inhibitor of Pyruvate kinase M2 (PKM2). Shikonin is the main ingredient of Lithosia, a Chinese herb with a variety of biological activities. Shikonin is a potent TMEM16A chloride channel inhibitor with an IC50 of 6.5 μM. Shikonin acts as an anti-inflammatory by inhibiting tumor necrosis factor-α (TNF-α), and it can inhibit the activation of nuclear factor-κB (NF-κB) signaling pathway. Shikonin decreases exosome secretion through the inhibition of glycolysis. Shikonin also inhibits AIM2 inflammasome activation.
Molecular Weight | 288.30 |
Formula | C16H16O5 |
CAS Number | 517-89-5 |
Solubility (25°C) | DMSO 100 mg/mL |
Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
[1] Zhenzhen Mu, et al. Therapeutic Effects of Shikonin on Skin Diseases: A Review
[4] Joelle C Boulos, et al. Shikonin derivatives for cancer prevention and therapy
Related TNF Receptor Products |
---|
Ozekibart
Ozekibart is an anti-TNFRSF10B monoclonal antibody. |
TAPI-0
TAPI-0 is a TACE (TNF-α converting enzyme; ADAM17) inhibitor with an IC50 of 100 nM. |
Semapimod tetrahydrochloride
Semapimod tetrahydrochloride (CNI-1493), an inhibitor of proinflammatory cytokine production, can inhibit TNF-α, IL-1β, and IL-6. |
BMS-566394
BMS-566394 is a potent, exceptionally selective inhibitor of TNF-α converting enzyme (TACE). |
APVO603
APVO603 is a dual agonist bispecific antibody employing a novel mechanism of action to simultaneously target 4-1BB (CD137) and OX40 (CD134), both members of the TNF-receptor family. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.